Lantern Pharma, Inc. (LTRN)
2.61
-0.16
(-5.78%)
USD |
NASDAQ |
Feb 20, 16:00
2.56
-0.05
(-1.92%)
After-Hours: 20:00
Lantern Pharma EPS Diluted (Quarterly) : -0.3856 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.177M |
| Total Expenses (Quarterly) | 4.177M |
| Enterprise Value | 16.92M |
| Earnings Yield | -67.15% |
| Normalized Earnings Yield | -67.15 |